North Crest Asset Manangement, LLC Neurocrine Biosciences Inc Transaction History
North Crest Asset Manangement, LLC
- $3.54 Billion
- Q2 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 6,262 shares of NBIX stock, worth $893,274. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,262
Previous 5,793
8.1%
Holding current value
$893,274
Previous $640,000
22.97%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
661Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$794 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$637 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$440 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...